Saturday, April 05, 2014 12:23:07 PM
Granted, ENMD has an infinite capacity to disappoint, but looking at the amount of
stock picked up via options at $1.83, I am seeing 100,000, 130,000, 150,000 shares
which requires a fairly decent commitment of cash. Hard to believe this would be the case
with bad news going on at the trials.
TB, am I looking at this correctly. Hope has a way of clouding judgment, so I would appreciate
your always well grounded comments. I do understand that we are probably a long way from
approval for sale. Thanks in advance.
Broadway
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM